Combination chemotherapy for malignant paraganglioma

被引：15

作者：

Kimura, S ^{[1
]}

Iwai, M ^{[1
]}

Fukuda, T ^{[1
]}

Akamatsu, T ^{[1
]}

Ochi, F ^{[1
]}

Masugi, J ^{[1
]}

Nakano, O ^{[1
]}

Sakamoto, T ^{[1
]}

Fukunaga, H ^{[1
]}

Amano, M ^{[1
]}

Fujimori, T ^{[1
]}

Maeda, S ^{[1
]}

机构：

[1] NISHIWAKI MUNICIPAL HOSP,DEPT MED,NISHIWAKI,JAPAN

来源：

INTERNAL MEDICINE | 1997年 / 36卷 / 01期

关键词：

retroperitoneal tumor; CVD regimen; hepatic metastasis;

D O I：

10.2169/internalmedicine.36.35

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treatment with a combination chemotherapeutic regimen consisting of cyclophosphamide, vincristine, and dacarbazine for malignant paraganglioma with hepatic metastasis is reported, A 51-year-old male presented with tumors in the retroperitoneal space and liver, The patient was diagnosed as having paraganglioma based on elevated levels of serum neuron-specific enolase, urinary catecholamine and vanillylmandelic acid, and on histological findings of the liver specimen, The patient was treated with this combination chemotherapy in repeated 21-day cycles, Temporary improvement in laboratory findings and a 20% reduction in the size of the hepatic masses were observed without severe adverse effects.

引用

页码：35 / 39

页数：5